Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol

被引：0
|
作者：
Qiang-ling Sun
Hui-fang Sha
Xiao-hua Yang
Guo-liang Bao
Jing Lu
Yin-yin Xie
机构：
[1] Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University,Basic Research Laboratory
[2] Ruijin Hospital of Shanghai Jiaotong University,Institute of Hematology
来源：
Journal of Cancer Research and Clinical Oncology | 2011年 / 137卷
关键词：
Chemoresistance; Non-Small Cell Lung Cancer (NSCLC); Paclitaxel; Two-dimensional difference gel electrophoresis (2D-DIGE);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：521 / 532
页数：11
相关论文
共 39 条
  • [31] RETRACTED: Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549 (Retracted article. See vol. 17, 2022)
    Wang, Tieliang
    Liu, Ying
    Wu, Chao
    NANOSCALE RESEARCH LETTERS, 2017, 12
  • [32] Cytoplasm-localized SIRT1 downregulation attenuates apoptosis and cell cycle arrest in cisplatin-resistant lung cancer A549 cells
    Yu, Hyeran
    Kim, Young Mee
    Cho, Moonjae
    JOURNAL OF CANCER, 2020, 11 (15): : 4495 - 4509
  • [33] Mesoporous Polydopamine Nano-Bowls Demonstrate a High Entrapment Efficiency and pH-Responsive Release of Paclitaxel for Suppressing A549 Lung Cancer Cell Proliferation In Vitro
    Ngema, Lindokuhle M.
    Acter, Shahinur
    Adeyemi, Samson A.
    Marimuthu, Thashree
    Govender, Mershen
    Ngwa, Wilfred
    Choonara, Yahya E.
    PHARMACEUTICS, 2024, 16 (12)
  • [34] TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ
    Qin, Xia
    Qiu, Feng
    Zou, Zhen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 568 - 572
  • [35] The effects of S-phase kinase-associated protein 2 (SKP2) on cell cycle status, viability, and chemoresistance in A549 lung adenocarcinoma cells
    Ishii, T
    Matsuse, T
    Masuda, M
    Teramoto, S
    EXPERIMENTAL LUNG RESEARCH, 2004, 30 (08) : 687 - 703
  • [36] Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin
    Yang, Yang
    Fan, Yuxia
    Qi, Yu
    Liu, Donglei
    Wu, Kai
    Wen, Fengbiao
    Zhao, Song
    ONCOLOGY REPORTS, 2015, 34 (02) : 929 - 935
  • [37] Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line
    Keenan, Joanne
    Murphy, Lisa
    Henry, Michael
    Meleady, Paula
    Clynes, Martin
    PROTEOMICS, 2009, 9 (06) : 1556 - 1566
  • [38] PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant
    Duraj, J
    Takacsova, X
    Sedlak, J
    Sulikova, M
    Hunakova, L
    Bies, J
    Chorvath, B
    ANTICANCER RESEARCH, 2000, 20 (6B) : 4627 - 4632
  • [39] Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach
    Pan, Shu-Ting
    Zhou, Zhi-Wei
    He, Zhi-Xu
    Zhang, Xueji
    Yang, Tianxin
    Yang, Yin-Xue
    Wang, Dong
    Qiu, Jia-Xuan
    Zhou, Shu-Feng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 937 - 968
1234